Jian Jin

Active 1995–2026

620
Papers
53,526
Citations
127
h-index
446
i10-index

Citations

Citations per year for Jian Jin1987: 3 citations1997: 1 citations1998: 4 citations1999: 2 citations2000: 4 citations2001: 6 citations2002: 4 citations2003: 8 citations2004: 7 citations2005: 10 citations2006: 10 citations2007: 14 citations2008: 19 citations2009: 17 citations2010: 51 citations2011: 74 citations2012: 148 citations2013: 293 citations2014: 419 citations2015: 477 citations2016: 634 citations2017: 676 citations2018: 677 citations2019: 1,391 citations2020: 1,541 citations2021: 1,813 citations2022: 1,934 citations2023: 1,783 citations2024: 2,569 citations2025: 1,528 citations2026: 119 citations1988–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 5,182 citing papers, 28.4% of this breakdownUnited States: 3,827 citing papers, 20.9% of this breakdownUnited Kingdom: 865 citing papers, 4.7% of this breakdownGermany: 672 citing papers, 3.7% of this breakdownIndia: 567 citing papers, 3.1% of this breakdownCanada: 516 citing papers, 2.8% of this breakdownItaly: 464 citing papers, 2.5% of this breakdownAustralia: 453 citing papers, 2.5% of this breakdownJapan: 382 citing papers, 2.1% of this breakdownFrance: 377 citing papers, 2.1% of this breakdownSouth Korea: 339 citing papers, 1.9% of this breakdownSpain: 290 citing papers, 1.6% of this breakdown
0%28.4%Other 23.7%

Fields

  • Biochemistry, Genetics and Molecular Biology39.1%
  • Medicine14.8%
  • Engineering7.9%
  • Computer Science7.6%
  • Agricultural and Biological Sciences6.1%
  • Environmental Science4.1%
  • Other20.4%

Topics

  • Protein Degradation and Inhibitors3.6%
  • Epigenetics and DNA Methylation3.3%
  • Ubiquitin and proteasome pathways2.4%
  • Cancer-related gene regulation2.1%
  • RNA modifications and cancer1.5%
  • Receptor Mechanisms and Signaling1.4%
  • Other85.7%

Coauthors

All papers

Open in search
  1. Advancing targeted protein degradation for cancer therapy

    Authors: , , , , , - Nature reviews. Cancer 2021 cited by 611

  2. Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions

    Authors: , , , , , , - Medicinal Research Reviews 2020 cited by 404

  3. Cancer Selective Target Degradation by Folate-Caged PROTACs

    Authors: , , , , , , , - Journal of the American Chemical Society 2021 cited by 288

  4. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis

    Authors: , , , , , , , , , , , , , , , - JAMA 2021 cited by 344

  5. Light-induced control of protein destruction by opto-PROTAC

    Authors: , , , , , , , , , , , - Science Advances 2020 cited by 278

  6. TF-PROTACs Enable Targeted Degradation of Transcription Factors

    Authors: , , , , , , - Journal of the American Chemical Society 2021 cited by 233

  7. Pharmacologic modulation of RNA splicing enhances anti-tumor immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jedd D. Wolchok, Taha Merghoub, Luis A. Díaz, Omar Abdel‐Wahab, Robert K. Bradley - Cell 2021 cited by 289

  8. Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets

    Authors: , , , , , , , , , , , - Journal of the American Chemical Society 2022 cited by 129

  9. Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease

    Authors: , , , - Nature Reviews Drug Discovery 2021 cited by 228

  10. The promise and peril of chemical probes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Derek Lowe, Mary M. Mader, Brian D. Marsden, Anke Mueller‐Fahrnow, Susanne Müller, Rónán C. O’Hagan, John P. Overington, Dafydd R. Owen, Saul H. Rosenberg, Ruth A. Ross, Bryan L. Roth, Matthieu Schapira, Stuart L. Schreiber, Brian K. Shoichet, M. Sundström, Giulio Superti-Furga, Jack Taunton, Leticia Toledo‐Sherman, Chris Walpole, Michael A. Walters, Timothy M. Willson, Paul Workman, Robert N. Young, William J. Zuercher - Nature Chemical Biology 2015 cited by 850

  11. Structure, function and pharmacology of human itch GPCRs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2021 cited by 224

  12. EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis

    Authors: , , , , , , , , , , , , , , , , - Nature Cell Biology 2022 cited by 183

  13. Stimuli-activatable PROTACs for precise protein degradation and cancer therapy

    Authors: , , , , , , , , , , , , , , , - Science Bulletin 2023 cited by 77

  14. Effects of sonication on the in vitro digestibility and structural properties of buckwheat protein isolates

    Authors: , , , - Ultrasonics Sonochemistry 2020 cited by 170

  15. A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models

    Authors: , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 157

  16. Folate-Guided Protein Degradation by Immunomodulatory Imide Drug-Based Molecular Glues and Proteolysis Targeting Chimeras

    Authors: , , , , - Journal of Medicinal Chemistry 2021 cited by 112

  17. The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells

    Authors: , , , , , , , , , , - Science Signaling 2022 cited by 107

  18. Current and future applications of statistical machine learning algorithms for agricultural machine vision systems

    Authors: , , , , - Computers and Electronics in Agriculture, Comput. Electron. Agric. 2018 cited by 410

  19. Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jian Jin, Ari Melnick, Tiziana Bonaldi, Omar Abdel‐Wahab, Ernesto Guccione - Cancer Cell 2019 cited by 279

  20. Repetitive transcranial magnetic stimulation increases the brain’s drainage efficiency in a mouse model of Alzheimer’s disease

    Authors: , , , , , , , , , - Acta Neuropathologica Communications 2021 cited by 127

  21. Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation

    Authors: , , , , , , , , , , , , , , , - Journal of the American Chemical Society 2021 cited by 140

  22. Mining online reviews with a Kansei-integrated Kano model for innovative product design

    Authors: , , - International Journal of Production Research, Int. J. Prod. Res. 2021 cited by 122

  23. Transformative Network Modeling of Multi-omics Data Reveals Detailed Circuits, Key Regulators, and Potential Therapeutics for Alzheimer’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Zhu, Pavel Katsel, Sam Gandy, Michelle E. Ehrlich, Valentina Fossati, Scott Noggle, Dongming Cai, Vahram Haroutunian, Koichi Iijima, Eric E. Schadt, Kristen Brennand, Bin Zhang - Neuron 2020 cited by 212

  24. PRMT inhibition induces a viral mimicry response in triple-negative breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Chemical Biology 2022 cited by 122